AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of “monoclonal gammopathy of inflammatory significance”?-Reference-Cited by-同舟云学术

AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of “monoclonal gammopathy of inflammatory significance”?

Published:2021-09-21 Issue:11 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Terré Alexandre¹²^ORCID,Colombat Magali³,Cez Alexandre⁴,Martin Claire⁵,Diet Carine⁶,Brechignac Sabine⁷,Oghina Silvia⁸,Bodez Diane⁹,Faguer Stanislas¹⁰,Savey Léa¹,Galland Joris¹,Boffa Jean‐Jacques⁶,Grateau Gilles¹¹¹,Jaccard Arnaud¹²,Buob David¹³,Georgin‐Lavialle Sophie¹¹¹

Affiliation:

1. Department of Internal Medicine Centre de référence des maladies auto‐inflammatoires et des amyloses d'origine inflammatoire (CEREMAIA) Sorbonne University, AP‐HP, Tenon Hospital Paris France

2. Laboratoire d'Excellence GR‐Ex Institut Imagine INSERM U1163 CNRS ERL 8254 Université Paris Descartes, Sorbonne Paris‐Cité Paris France

3. Department of Pathology CHU Toulouse Toulouse France

4. Department of Nephrology Sorbonne UniversityTenon Hospital Paris France

5. Rheumatology Department La Rochelle Hospital La Rochelle France

6. Nephrology Department Henri Mondor Hospital Creteil France

7. Haematology Department Avicenne Hospital Bobigny France

8. Cardiology Department Henri Mondor HospitalNational Reference Centre of Cardiac Amyloidosis Creteil France

9. Cardiology Department Centre Cardiologique du Nord Saint‐Denis France

10. Département de Néphrologie et Transplantation d'Organes CHU de Toulouse Toulouse France

11. Inserm UMRS_933, et laboratoire de génétique Faculté de médecine Sorbonne UniversityTrousseau Hospital, AP‐HP Paris France

12. Haematology Department CHU Dupuytren National Reference Center for AL Amyloidosis Limoges France

13. Department of Pathology Sorbonne UniversityTenon Hospital Paris France

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14817

Reference26 articles.

1. AL amyloidosis: from molecular mechanisms to targeted therapies

2. AA Amyloidosis: Pathogenesis and Targeted Therapy

3. Natural History and Outcome in Systemic AA Amyloidosis

4. Schnitzler's syndrome: diagnosis, treatment, and follow-up

5. Causes of AA amyloidosis: a systematic review

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal of a new clinical entity: Paraprotein negative IL-1 mediated inflammatory dermatosis (PANID) that may precede Schnitzler syndrome;World Allergy Organization Journal;2023-09

2. Intestinal Reactive Amyloid A (AA) Amyloidosis in a Patient With Multiple Myeloma: A Case Report and Literature Review;Cureus;2023-08-03

3. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review;Kidney International;2023-03

4. Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma;International Journal of Molecular Sciences;2022-11-25

5. Noninvasive Diagnostics of Renal Amyloidosis: Current State and Perspectives;International Journal of Molecular Sciences;2022-10-21